Patents by Inventor Janet C. Gonder

Janet C. Gonder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemoglobin therapy in hemodialysis
    Patent number: 6114303
    Abstract: Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: September 5, 2000
    Assignee: Baxter International, Inc.
    Inventors: John Blue, Jan W. Garber, Janet C. Gonder, Gary R. Marchand, Robert J. Przybelski, Kathleen N. Stern
  • Hemoglobin therapy in hemodialysis
    Patent number: 5906974
    Abstract: Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: May 25, 1999
    Assignee: Baxter International, Inc.
    Inventors: John Blue, Jan W. Garber, Janet C. Gonder, Gary R. Marchand, Robert J. Przybelski, Kathleen N. Stern